Form Type: 4

SEC EDGAR Link
Accession Number:0001354488-15-005343
Date:2015-11-16
Issuer: CELLULAR BIOMEDICINE GROUP, INC. (CBMG)
Original Submission Date:

Reporting Person:

CAO WEI (WILLIAM)
19925 STEVENS CREEK BLVD., SUITE 100
CUPERTINO, CA 95014

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2015-11-16 S 12,066 d $23.55 210,452 direct
COMMON STOCK 2015-11-17 S 14,749 d $25.53 195,703 direct
COMMON STOCK 2015-11-18 S 11,231 d $22.83 184,472 direct
COMMON STOCK 2015-11-19 S 10,000 d $21.15 174,472 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the transaction reported was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on june 30, 2015. accordingly, the reporting person had no discretion with regard to the timing of the transaction.
WhaleWisdom Logo

Elevate your investments